Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study
- Budde, L.E.
- Sehn, L.H.
- Matasar, M.
- Schuster, S.J.
- Assouline, S.
- Giri, P.
- Kuruvilla, J.
- Canales, M.
- Dietrich, S.
- Fay, K.
- Ku, M.
- Nastoupil, L.
- Cheah, C.Y.
- Wei, M.C.
- Yin, S.
- Li, C.-C.
- Huang, H.
- Kwan, A.
- Penuel, E.
- Bartlett, N.L.
ISSN: 1474-5488, 1470-2045
Year of publication: 2022
Volume: 23
Issue: 8
Pages: 1055-1065
Type: Article